GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (FRA:2M6) » Definitions » Cyclically Adjusted Price-to-FCF

Medtronic (FRA:2M6) Cyclically Adjusted Price-to-FCF : 18.67 (As of Apr. 28, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Medtronic Cyclically Adjusted Price-to-FCF?

As of today (2024-04-28), Medtronic's current share price is €73.93. Medtronic's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2024 was €3.96. Medtronic's Cyclically Adjusted Price-to-FCF for today is 18.67.

The historical rank and industry rank for Medtronic's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:2M6' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 15.78   Med: 23.87   Max: 34.08
Current: 18.55

During the past years, Medtronic's highest Cyclically Adjusted Price-to-FCF was 34.08. The lowest was 15.78. And the median was 23.87.

FRA:2M6's Cyclically Adjusted Price-to-FCF is ranked better than
78.17% of 229 companies
in the Medical Devices & Instruments industry
Industry Median: 42.33 vs FRA:2M6: 18.55

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Medtronic's adjusted free cash flow per share data for the three months ended in Jan. 2024 was €1.467. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €3.96 for the trailing ten years ended in Jan. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medtronic Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Medtronic's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Cyclically Adjusted Price-to-FCF Chart

Medtronic Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.58 25.22 33.08 24.44 20.62

Medtronic Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.69 20.62 19.93 16.20 20.36

Competitive Comparison of Medtronic's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted Price-to-FCF falls into.



Medtronic Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Medtronic's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=73.93/3.96
=18.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Medtronic's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=1.467/120.1096*120.1096
=1.467

Current CPI (Jan. 2024) = 120.1096.

Medtronic Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201404 0.875 100.673 1.044
201407 0.148 100.573 0.177
201410 0.645 100.274 0.773
201501 1.436 98.779 1.746
201504 1.063 99.975 1.277
201507 0.375 100.374 0.449
201510 0.659 100.075 0.791
201601 1.004 98.879 1.220
201604 0.605 99.875 0.728
201607 0.785 100.872 0.935
201610 0.785 99.776 0.945
201701 1.195 99.178 1.447
201704 0.975 100.773 1.162
201707 0.289 100.673 0.345
201710 0.412 100.374 0.493
201801 1.060 99.377 1.281
201804 0.445 100.374 0.532
201807 0.885 101.470 1.048
201810 0.612 101.271 0.726
201901 1.135 100.075 1.362
201904 1.154 102.068 1.358
201907 0.798 101.969 0.940
201910 1.060 101.969 1.249
202001 1.409 101.371 1.669
202004 0.759 101.969 0.894
202007 -0.036 101.570 -0.043
202010 0.993 100.474 1.187
202101 1.207 101.171 1.433
202104 0.842 103.065 0.981
202107 0.570 103.763 0.660
202110 0.953 105.557 1.084
202201 1.243 106.255 1.405
202204 1.149 110.242 1.252
202207 0.484 113.232 0.513
202210 0.456 115.226 0.475
202301 0.865 114.528 0.907
202304 1.425 118.216 1.448
202307 0.353 119.811 0.354
202310 0.142 121.106 0.141
202401 1.467 120.110 1.467

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medtronic  (FRA:2M6) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Medtronic Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Medtronic's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medtronic (FRA:2M6) Business Description

Address
Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Medtronic (FRA:2M6) Headlines

No Headlines